Nucleotide receptor signaling in platelets

被引:156
作者
Kahner, B. N. [1 ]
Shankar, H. [1 ]
Murugappan, S. [1 ]
Prasad, G. L. [1 ]
Kunapuli, S. P. [1 ]
机构
[1] Temple Univ, Sch Med, Dept Physiol, Cell Signaling Grp, Philadelphia, PA 19122 USA
关键词
G(i); GPCR; G(q); P2X(1); P2Y(1); P2Y(12);
D O I
10.1111/j.1538-7836.2006.02192.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Upon injury to a vessel wall the exposure of subendothelial collagen results in the activation of platelets. Platelet activation culminates in shape change, aggregation, release of granule contents and generation of lipid mediators. These secreted and generated mediators trigger a positive feedback mechanism potentiating the platelet activation induced by physiological agonists such as collagen and thrombin. Adenine nucleotides, adenosine diphosphate (ADP) and adenosine triphosphate (ATP), released from damaged cells and that are secreted from platelet-dense granules, contribute to the positive feedback mechanism by acting through nucleotide receptors on the platelet surface. ADP acts through two G protein-coupled receptors, the G(q)-coupled P2Y(1) receptor, and the G(i)-coupled P2Y(12) receptor. ATP, on the other hand, acts through the ligand-gated channel P2X(1). Stimulation of platelets by ADP leads to shape change, aggregation and thromboxane A(2) generation. ADP-induced dense granule release depends on generated thromboxane A(2). Furthermore, costimulation of both P2Y(1) and P2Y(12) receptors is required for ADP-induced platelet aggregation. ATP stimulation of P2X(1) is involved in platelet shape change and helps to amplify platelet responses mediated by agonists such as collagen. Activation of each of these nucleotide receptors results in unique signal transduction pathways that are important in the regulation of thrombosis and hemostasis.
引用
收藏
页码:2317 / 2326
页数:10
相关论文
共 128 条
[1]   PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS [J].
ABBRACCHIO, MP ;
BURNSTOCK, G .
PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) :445-475
[2]   Phosphopleckstrin inhibits G beta gamma-activable platelet phosphatidylinositol-4,5-bisphosphate 3-kinase [J].
Abrams, CS ;
Zhang, J ;
Downes, CP ;
Tang, XW ;
Zhao, W ;
Rittenhouse, SE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (41) :25192-25197
[3]   P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries [J].
André, P ;
Delaney, SM ;
LaRocca, T ;
Vincent, D ;
DeGuzman, F ;
Jurek, M ;
Koller, B ;
Phillips, DR ;
Conley, PB .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) :398-406
[4]   Cloning and chromosomal localization of the human P2Y1 purinoceptor [J].
Ayyanathan, K ;
Webbs, TE ;
Sandhu, AK ;
Athwal, RS ;
Barnard, EA ;
Kunapuli, SP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 218 (03) :783-788
[5]   Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor [J].
Azim, AC ;
Barkalow, K ;
Chou, J ;
Hartwig, JH .
BLOOD, 2000, 95 (03) :959-964
[6]   Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets [J].
Bauer, M ;
Retzer, M ;
Wilde, JI ;
Maschberger, P ;
Essler, M ;
Aepfelbacher, M ;
Watson, SP ;
Siess, W .
BLOOD, 1999, 94 (05) :1665-1672
[7]   Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist [J].
Baurand, A ;
Raboisson, P ;
Freund, M ;
Léon, C ;
Cazenave, JP ;
Bourguignon, JJ ;
Gachet, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 412 (03) :213-221
[8]   INOSITOL TRISPHOSPHATE AND CALCIUM SIGNALING [J].
BERRIDGE, MJ .
NATURE, 1993, 361 (6410) :315-325
[9]   Relationships between Rap1b, affinity modulation of integrin αIIbβ3, and the actin cytoskeleton [J].
Bertoni, A ;
Tadokoro, S ;
Eto, K ;
Pampori, N ;
Parise, LV ;
White, GC ;
Shattil, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) :25715-25721
[10]  
Boyer JL, 1996, MOL PHARMACOL, V50, P1323